Zoono Group Ltd represents a core set of values and a strong corporate philosophy. As a company, Zoono is committed to innovation, transparency, and sustainability. It values continuous improvement and strives to deliver high-quality products and services to its customers. Zoono Group Ltd believes in building strong relationships with stakeholders, including employees, customers, and partners, based on trust and mutual respect. The company's philosophy revolves around responsible business practices, ethical decision-making, and fostering a positive and inclusive work environment. Zoono Group Ltd aims to make a positive impact on society by providing effective and safe antimicrobial solutions.

Zoono Group Ltd is primarily present in several countries and regions worldwide. These include Australia, New Zealand, the United Kingdom, Europe, the United States, Canada, Asia, and the Middle East.

Zoono Group Ltd, a leading company in the antimicrobial industry, has achieved several significant milestones. Firstly, Zoono gained global recognition for its innovative and highly effective antimicrobial technology, which provides long-lasting protection against a wide range of pathogens. Additionally, the company successfully expanded its product range, catering to various industries including healthcare, consumer, and industrial sectors. Zoono Group Ltd also established strong partnerships with renowned organizations worldwide, enhancing its market presence and distribution capabilities. Furthermore, the company's shares have been listed on prestigious stock exchanges such as the Australian Securities Exchange (ASX) and the London Stock Exchange (LSE), providing investors with increased opportunities. Overall, Zoono Group Ltd has consistently demonstrated its commitment to pioneering antimicrobial solutions and achieving remarkable business growth.

Zoono Group Ltd is a leading company that specializes in the development and production of long-lasting antimicrobial solutions. Established in New Zealand, the company was founded in 2008 and has since expanded its operations globally. Zoono's innovative technology utilizes a unique bonding process that forms a protective barrier capable of eliminating a wide range of bacteria, viruses, and fungi. With a strong commitment to research and development, Zoono has continuously evolved its product offerings, including hand sanitizers, surface sprays, and other disinfecting solutions. Today, Zoono Group Ltd is recognized as a trusted provider of safe and effective antimicrobial protection worldwide.

The main competitors of Zoono Group Ltd in the market include companies such as Microban International, Clorox Company, Reckitt Benckiser Group plc, and 3M Company.

Zoono Group Ltd is primarily active in the industries of biotechnology, consumer goods, and healthcare.

The business model of Zoono Group Ltd revolves around the development, manufacture, and distribution of a range of antimicrobial solutions. Zoono Group focuses on creating and marketing innovative long-lasting disinfectant products for various applications, including commercial, industrial, and personal use. Their scientifically advanced formulations provide a protective barrier against harmful microbes, delivering extended germ protection. Zoono's products have gained recognition for their effectiveness, durability, and environmentally friendly features. As a leading company in the antimicrobial industry, Zoono Group Ltd continually strives to enhance their product portfolio and expand their global presence.

Az KGV a Zoono Group esetében jelenleg nem számítható ki.

A Zoono Group számára az aktuális KUV nem számítható ki.

Az AlleAktien Minőségi Score Zoono Group esetében 2/10.

A Zoono Group esetében jelenleg nem számítható ki az árbevétel.

A nyereséget jelenleg nem lehet kiszámítani a Zoono Group számára.

The company Zoono Group Ltd is a specialist in antimicrobial technologies and offers products and services in various areas. The company is based in New Zealand and operates globally. Zoono's core business offers various antimicrobial solutions based on quaternary ammonium compounds and silver ions. These technologies effectively fight bacteria, viruses, and fungi, reducing the risk of infections. Zoono's business model involves developing, manufacturing, and distributing these technologies. One of Zoono's crucial sectors is the production of products for use in medicine. This includes antiseptic solutions for skin and hand disinfection, as well as wound disinfectants. These products are particularly crucial in hospitals and other medical facilities, where the spread of infections is a significant problem. Another important area in which Zoono operates is the food industry. This includes antimicrobial coatings for packaging and surfaces in food facilities to prevent the growth of bacteria and mold and extend the shelf life of food. Zoono also offers solutions for air and surface disinfection. Zoono's technologies can be used in ventilation systems, air conditioning, and rooms to reduce the spread of bacteria and viruses, thereby minimizing the risk of infection. Furthermore, Zoono offers products for personal use. This includes deodorants, mouthwashes, and hand sanitizers. These products are also intended for use by the general public and aim to reduce the overall risk of infection in society. Recently, the company has also begun to bring its antimicrobial technologies into the field of animal care. This includes antimicrobial dog protection products and products for disinfecting animal shelters and veterinary clinics. In summary, Zoono's business model involves developing, manufacturing, and distributing antimicrobial technologies. The company operates in various areas and sectors, including medicine, the food industry, air and surface disinfection, personal use, and animal care. By providing these products and services, Zoono helps reduce the risk of infection and improve the health and safety of humans and animals.

A(z) Zoono Group évente alkalommal oszt ki 0 NZD összegű osztalékot.

A Zoono Group esetében jelenleg nem lehet kiszámítani a osztalékot, vagy a vállalat nem fizet osztalékot.

A(z) Zoono Group ISIN kódja: AU000000ZNO4.

A Zoono Group WKN-je A2PZCA.

Az Zoono Group tőzsdei rövidítése ZNO.AX.

Az elmúlt 12 hónapban a(z) Zoono Group osztalékot fizetett 0,03 NZD összegben. Ez körülbelül 92,94 % osztalékhozamnak felel meg. A következő 12 hóban a(z) Zoono Group várhatóan 0 NZD összegű osztalékot fog fizetni.

A(z) Zoono Group jelenlegi osztalékhozama 92,94 %.

A(z) Zoono Group negyedévente fizet osztalékot. Az osztalékokat a következő hónapokban osztják ki: .

A Zoono Group az elmúlt 0 évben minden évben fizetett osztalékot.

A következő 12 hónapban 0 NZD összegű osztalékra számítanak. Ez 0 % osztalékhozamnak felel meg.

A(z) Zoono Group a(z) 'Alapanyagok' szektorhoz van besorolva.

Az utolsó, Zoono Group által 2020. 09. 21.-án/én fizetett 0,03 NZD összegű osztalék megszerzéséhez a részvénynek az ex-nap előtti 2020. 09. 04.-nál kellett lennie a portfóliódban.

Az utolsó osztalék kifizetése 2020. 09. 21. időpontban történt.

2023 évben a Zoono Group 0 NZD összegű osztalékot fizetett ki.

Az Zoono Group osztalékait NZD fizeti ki.